Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.
Human pluripotent stem cells, including embryonic (hES) and induced pluripotent stem cells (hiPS), retain the ability to self-renew indefinitely, while maintaining the capacity to differentiate into all cell types of the nervous system. While human pluripotent cell-based therapies are unlikely to arise soon, these cells can currently be used as an inexhaustible source of committed neurons to perform high-throughput screening and safety testing of new candidate drugs. Here, we describe critically the available methods and molecular factors that are used to direct the differentiation of hES or hiPS into specific neurons. In addition, we discuss how the availability of patient-specific hiPS offers a unique opportunity to model inheritable neurodegenerative diseases and untangle their pathological mechanisms, or to validate drugs that would prevent the onset or the progression of these neurological disorders.
GIGA-Neurosciences, University of Liege, Liege, Belgium. bmalgrange@ulg.ac.be
Brigitte
B
Malgrange
Laurence
L
Borgs
Benjamin
B
Grobarczyk
Audrey
A
Purnelle
Patricia
P
Ernst
Gustave
G
Moonen
Laurent
L
Nguyen
D000818:Animals; D002454:Cell Differentiation; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D019636:Neurodegenerative Diseases / Q000378:metabolism* / Q000473:pathology; D009474:Neurons / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D039904:Pluripotent Stem Cells / Q000166:cytology* / Q000378:metabolism / Q000473:pathology